13, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and ...
According to IBM, they are pioneering a new “quantum-centric supercomputing” approach to model complex chemical and biological processes that weren’t possible before. Previously, it was thought that ...
Once inside, the T-cells attack all cancer cells that carry the recognized structure. From pro- to anti-tumor The CAR T-cells developed by Hutter's team have an extra feature aimed at altering the ...